Advertisement

Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction

      Clinical and angiographic data were analyzed from 929 patients who had ST-elevation myocardial infarction and open epicardial arteries after fibrinolytic therapy. Residual angiographically evident thrombus was associated with more frequent Thrombolysis In Myocardial Infarction (TIMI) grade 2 flow (33.6% vs 26.8%, p = 0.03), higher corrected TIMI frame counts (34 vs 31 frames, p = 0.0003), and lower TIMI myocardial perfusion grades (43.0% vs 32.0% TIMI myocardial perfusion grades 0/1, p = 0.001) among all patients and among patients who had TIMI grade 3 flow (33.5% vs 26.0% TIMI myocardial perfusion grades 0/1, p = 0.043). In multivariate analyses, angiographically evident thrombus was associated with higher corrected TIMI frame counts and worsened myocardial perfusion independent of clinical and angiographic covariates, including TIMI grade 3 flow.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Okamatsu K.
        • Takano M.
        • Sakai S.
        • Ishibashi F.
        • Uemura R.
        • Takano T.
        • Mizuno K.
        Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes.
        Circulation. 2004; 109: 465-470
        • Wong G.C.
        • Morrow D.A.
        • Murphy S.
        • Kraimer N.
        • Pai R.
        • James D.
        • Robertson D.H.
        • Demopoulos L.A.
        • DiBattiste P.
        • Cannon C.P.
        • Gibson C.M.
        Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy.
        Circulation. 2002; 106: 202-207
        • Ross M.J.
        • Herrmann H.C.
        • Moliterno D.J.
        • Blankenship J.C.
        • Demopoulos L.
        • DiBattiste P.M.
        • Ellis S.G.
        • Ghazzal Z.
        • Martin J.L.
        • White J.
        • Topol E.J.
        Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial.
        J Am Coll Cardiol. 2003; 42: 981-988
        • Willerson J.T.
        • Golino P.
        • Eidt J.
        • Campbell W.B.
        • Buja L.M.
        Specific platelet mediators and unstable coronary artery lesions.
        Circulation. 1989; 80: 198-205
        • Antman E.M.
        • Giugliano R.P.
        • Gibson C.M.
        • McCabe C.H.
        • Coussement P.
        • Kleiman N.S.
        • Vahanian A.
        • Adgey A.A.
        • Menown I.
        • Rupprecht H.J.
        • et al.
        Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial.
        Circulation. 1999; 99: 2720-2732
        • Giugliano R.P.
        • Roe M.T.
        • Harrington R.A.
        • Gibson C.M.
        • Zeymer U.
        • Van de Werf F.
        • Baran K.W.
        • Hobbach H.P.
        • Woodlief L.H.
        • Hannan K.L.
        • et al.
        Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the Integrilin and Tenecteplase in Acute Myocardial Infarction (INTEGRITI) Phase II Angiographic Trial.
        J Am Coll Cardiol. 2003; 41: 1251-1260
        • Antman E.M.
        • Louwerenburg H.W.
        • Baars H.F.
        • Wesdorp J.C.
        • Hamer B.
        • Bassand J.P.
        • Bigonzi F.
        • Pisapia G.
        • Gibson C.M.
        • Heidbuchel H.
        • et al.
        Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.
        Circulation. 2002; 105: 1642-1649
      1. Ohman EM, Van de Werf F, Antman EM, Califf RM, Lemos JAD, Gibson CM, Oliverio RL, Harrelson L, McCabe C, DiBattiste P, et al. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial. Am Heart J 2005; in press.

        • Gibson C.M.
        • Cannon C.P.
        • Daley W.L.
        • Dodge Jr, J.T.
        • Alexander Jr, B.
        • Marble S.J.
        • McCabe C.H.
        • Raymond L.
        • Fortin T.
        • Poole W.K.
        • Braunwald E.
        TIMI frame count: a quantitative method of assessing coronary artery flow.
        Circulation. 1996; 93: 879-888
        • Gibson C.M.
        • Cannon C.P.
        • Murphy S.A.
        • Ryan K.A.
        • Mesley R.
        • Marble S.J.
        • McCabe C.H.
        • Van De Werf F.
        • Braunwald E.
        Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.
        Circulation. 2000; 101: 125-130
      2. STATA Statistical Software. College Station, TX: STATA Corp., 2000.

        • Gibson C.M.
        • Murphy S.
        • Menown I.B.
        • Sequeira R.F.
        • Greene R.
        • Van de Werf F.
        • Schweiger M.J.
        • Ghali M.
        • Frey M.J.
        • Ryan K.A.
        • et al.
        Determinants of coronary blood flow after thrombolytic administration.
        J Am Coll Cardiol. 1999; 34: 1403-1412
        • Saber R.S.
        • Edwards W.D.
        • Bailey K.R.
        • McGovern T.W.
        • Schwartz R.S.
        • Holmes Jr, D.R.
        Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases.
        J Am Coll Cardiol. 1993; 22: 1283-1288
        • Fukuda D.
        • Tanaka A.
        • Shimada K.
        • Nishida Y.
        • Kawarabayashi T.
        • Yoshikawa J.
        Predicting angiographic distal embolization following percutaneous coronary intervention in patients with acute myocardial infarction.
        Am J Cardiol. 2003; 91: 403-407
        • Heusch G.
        • Schulz R.
        • Baumgart D.
        • Haude M.
        • Erbel R.
        Coronary microembolization.
        Prog Cardiovasc Dis. 2001; 44: 217-230
        • Merlini P.A.
        • Bauer K.A.
        • Oltrona L.
        • Ardissino D.
        • Spinola A.
        • Cattaneo M.
        • Broccolino M.
        • Mannucci P.M.
        • Rosenberg R.D.
        Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction.
        J Am Coll Cardiol. 1995; 25: 203-209
        • Gurbel P.A.
        • Serebruany V.L.
        • Shustov A.R.
        • Bahr R.D.
        • Carpo C.
        • Ohman E.M.
        • Topol E.J.
        Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment.
        J Am Coll Cardiol. 1998; 31: 1466-1473
        • Reil T.D.
        • Moore W.S.
        • Kashyap V.S.
        • Nene S.S.
        • Gelabert H.A.
        • Quinones-Baldrich W.J.
        The effects of thrombus, thrombectomy and thrombolysis on endothelial function.
        Eur J Vasc Endovasc Surg. 2000; 19: 162-168
        • Barron H.V.
        • Cannon C.P.
        • Murphy S.A.
        • Braunwald E.
        • Gibson C.M.
        Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a Thrombolysis In Myocardial Infarction 10 substudy.
        Circulation. 2000; 102: 2329-2334
      3. Stone GW, Webb J, Cox DA, Brodie BR, Quershi M, Dulas D, Kalynch A, Turco M, Schultheiss HP, Rutherford B, et al. Primary angioplasty in acute myocardial infarction with distal protection of the microcirculation: principal results from the prospective, randomized EMERALD trial. J Am Coll Cardiol 2004;43(5 suppl A):285A.